# Mental Intervention and Nicotinamide Riboside Supplementation in Long Covid

> **NCT05703074** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Akershus** · enrollment: 310 (actual)

## Conditions studied

- Long COVID

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside (NR)
- **BEHAVIORAL:** Mind-body reprocessing therapy (MBRT)
- **BEHAVIORAL:** Care as usual
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05703074
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-30
- **Primary completion:** 2024-09-23
- **Final completion:** 2025-07
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05703074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05703074, "Mental Intervention and Nicotinamide Riboside Supplementation in Long Covid". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05703074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*